Maintenance / Service
PRODUCTS
-
At the core of our comprehensive eClinical platform, iMednet EDC is uniquely designed to help sponsors and CROs achieve their clinical research goals. Highly flexible, it enables you to build studies quickly, while easily adapting to complex protocols and mid-study changes with ease.
-
Deliver cost-effective, reliable public infrastructure—from permitting and construction to operation, maintenance and replacement. From the office to the field, Trimble Cityworks helps you improve service to your community while increasing safety, efficiency and performance.
-
At inSeption Group, we don’t just crunch numbers—we transform data into confident action. Your trial’s success hinges on how well data is planned, analyzed, and delivered, and we make sure every finding moves your program forward.
-
The AMP20170 is a solid-state, high-power amplifier engineered to meet the demands of modern RF environments across various industries.
-
SearchLight™ is a free, intuitive, online plotting tool helps you overcome the obstacles many fluorescence instrument designers and users face with spectral management.
WHITE PAPERS AND CASE STUDIES
-
Endpoint Clinical RTSM: Getting The Job Done
Explore how a Job-to-be-Done (JTBD)-focused RTSM approach reduces delays, optimizes costs, and accelerates trial success through predictive intelligence and streamlined global workflows.
-
Kimberly-Clark Streamlines Supplier Management
Find out how Kimberly-Clark implemented software to centralize and secure supplier contract management to enhance efficiency and achieve a 3,200% ROI through streamlined processes.
-
Modernizing Operational Maintenance At Treatment Plants
In 2017, the Harford County Division of Water and Sewer began looking for a modern work management solution to help automate preventive maintenance, coordinate work activities between groups, manage material inventories, and capture important data.
-
CDMO Accelerates Contract Manufacturing With Electronic Batch Records
A prominent CDMO sought a specialized software solution to streamline and accelerate its manufacturing processes, enabling the efficient production of complex, customized products in record time.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Examining A Phase 1 COVID-19 Clinical Trial
Uncover how we were able to efficiently activate the site and enroll 130 participants within six months, demonstrating our expertise in clinical trial management.
-
The Untapped Power Of Real-World Data And AI In Pharma Commercialization
Harnessing RWD in commercialization bridges the gap between approval and patient access, equipping companies with actionable intelligence to deliver life-changing therapies to more patients.
-
Rapid And Robust Preclinical And Clinical Development Of CAR T-Cell Therapies
Streamline CAR T-cell therapy development with integrated support for asset identification, IND submission, early-phase studies, and advanced real-time tracking solutions.
-
Advancing QC Efficiency With SEC-MALS System And Empower Software
Discover how integration transforms lab workflows to enhance molecular characterization, streamline data management, and ensure compliance for superior data integrity and operational efficiency.
-
Advancing Multiomics Through Intelligent Automation
Modern automation tackles hidden pipetting errors and boosts reproducibility. Discover how your lab can scale confidently, reduce rework, and accelerate multiomic workflows with built-in traceability.
-
Seamlessly Integrating An E-WorkBook With A Customer's LIMS
Explore the story of a global biopharma company's integration of E-WorkBook with their LIMS, automating ADA study reports, saving significant time, and enhancing data accuracy.
-
Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
NEWS
-
Alpha Zero Global Logistics Announces Strategic Partnership With Turvo To Power Its Next-Generation Managed Transportation Platform2/19/2026
Alpha Zero Global Logistics (AZL), a growing leader in transportation and supply chain solutions, today announced a strategic partnership with Turvo, the collaboration-first Transportation Management System.
-
Wayvia Unveils New MCP-Powered Innovations To Help Brands Unlock Smarter Commerce Intelligence8/28/2025
Wayvia, the omnicommerce enablement leader formerly known as PriceSpider, today announced a series of new MCP-powered product innovations previewing the next wave of AI-driven commerce intelligence.
-
Grifols And Inpeco Joining Forces To Deliver Transfusion Medicine 'Lab Of The Future'3/20/2025
Grifols a global healthcare company and leading manufacturer of plasma-derived medicines and innovative diagnostic solutions, today announced it has signed a strategic agreement with Inpeco, a global leader in total laboratory automation technologies, to provide transfusion medicine labs with complete, tailored instrumentation, robotics and software capabilities to modernize their operations and make them more efficient.
-
Fischer Mechanical Partners With Byrne Software And Runding Corporation To Modernize Project Delivery And Field Operations8/19/2025
Fischer Mechanical, a fast growing St. Louis-based mechanical contractor, has selected Byrne Software Technologies in partnership with Runding Corporation to support its digital transformation initiative aimed at improving labor productivity, standardizing workflows, and enabling real-time job cost insights.
-
Zymeworks Receives U.S. FDA Fast Track Designation For ZW191, An Frα-Targeting Antibody-Drug Conjugate3/30/2026
Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ZW191, an antibody-drug conjugate (ADC) targeting folate receptor-α (FRα), for the treatment of patients with advanced or metastatic platinum-resistant ovarian cancer (PROC).